Daiwa Securities Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-214
| Closed | -$15K | – | 1434 |
|
|
2022
Q3 | $15K | Hold |
214
| – | – | ﹤0.01% | 1102 |
|
|
2022
Q2 | $7K | Hold |
214
| – | – | ﹤0.01% | 1146 |
|
|
2022
Q1 | $7K | Hold |
214
| – | – | ﹤0.01% | 1149 |
|
|
2021
Q4 | $6K | Hold |
214
| – | – | ﹤0.01% | 1180 |
|
|
2021
Q3 | $5K | Buy |
214
+98
| +84% | +$2.29K | ﹤0.01% | 1180 |
|
|
2021
Q2 | $4K | Hold |
116
| – | – | ﹤0.01% | 1095 |
|
|
2021
Q1 | $5K | Hold |
116
| – | – | ﹤0.01% | 1083 |
|
|
2020
Q4 | $5K | Sell |
116
-232
| -67% | -$10K | ﹤0.01% | 1062 |
|
|
2020
Q3 | $19K | Buy |
348
+8
| +2% | +$437 | ﹤0.01% | 990 |
|
|
2020
Q2 | $17K | Hold |
340
| – | – | ﹤0.01% | 1022 |
|
|
2020
Q1 | $17K | Hold |
340
| – | – | ﹤0.01% | 1011 |
|
|
2019
Q4 | $27K | Sell |
340
-42
| -11% | -$3.34K | ﹤0.01% | 986 |
|
|
2019
Q3 | $19K | Buy |
382
+24
| +7% | +$1.19K | ﹤0.01% | 989 |
|
|
2019
Q2 | $19K | Hold |
358
| – | – | ﹤0.01% | 1003 |
|
|
2019
Q1 | $19K | Buy |
358
+117
| +49% | +$6.21K | ﹤0.01% | 985 |
|
|
2018
Q4 | $10K | Hold |
241
| – | – | ﹤0.01% | 991 |
|
|
2018
Q3 | $9K | Hold |
241
| – | – | ﹤0.01% | 1039 |
|
|
2018
Q2 | $11K | Hold |
241
| – | – | ﹤0.01% | 1039 |
|
|
2018
Q1 | $12K | Buy |
+241
| New | +$12K | ﹤0.01% | 1010 |
|